Bain Capital Life Sciences Investors, LLC
SEC Form 4 insider trading activity
Bain Capital Life Sciences Investors, LLC has filed 3 SEC Form 4 filings (8 transaction rows) across 2 companies, including HTFL, KLRA, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: May 1, 2026.
On the most recent filing, Bain Capital Life Sciences Investors, LLC is listed as Insider at Heartflow, Inc. Inside the rolling window, Bain Capital Life Sciences Investors, LLC reported 1 open-market purchase totaling $25.0M in KLRA and 4 open-market sales totaling $115.0M in HTFL. The largest disclosed transaction in the window is a sale of 2,000,000 HTFL shares on Feb 4, 2026, worth $56.1M.
Companies traded
Other insiders at HTFL
Insider Buying
$25.0M
reported purchases (SEC code P)
Insider Selling
$115.0M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Bain Capital Life Sciences Investors, LLC made?
Bain Capital Life Sciences Investors, LLC has filed 3 SEC Form 4 filings (8 transaction rows) across 2 companies, including HTFL, KLRA since 2026.
Which companies does Bain Capital Life Sciences Investors, LLC trade?
Bain Capital Life Sciences Investors, LLC has filed SEC Form 4 disclosures for 2 companies, including HTFL, KLRA.
When was Bain Capital Life Sciences Investors, LLC's most recent SEC Form 4 filing?
Bain Capital Life Sciences Investors, LLC's most recent SEC Form 4 filing on Tracefour is dated May 1, 2026.
What is Bain Capital Life Sciences Investors, LLC's total buy and sell value in the current window?
Inside the rolling retention window, Bain Capital Life Sciences Investors, LLC bought $25.0M and sold $115.0M based on SEC Form 4 filings.
What was Bain Capital Life Sciences Investors, LLC's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,000,000 HTFL shares on 2026-02-04, worth $56.1M, per SEC Form 4 filings.